Nanobiotix S.A. Financial Assets At Fair Value
Nanobiotix S.A. (NBTX) had Financial Assets At Fair Value of EUR 55.32 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:FinancialAssetsAtFairValue · last filed 2026-03-31
- 2025-12-31: Financial Assets At Fair Value 55.32M EUR.
- 2025-06-30: Financial Assets At Fair Value 31.06M EUR.
- 2024-12-31: Financial Assets At Fair Value 53.12M EUR.
- 2024-06-30: Financial Assets At Fair Value 69.76M EUR.
| Period end | Financial Assets At Fair Value |
|---|---|
| 2025-12-31 | 55.32M EUR 20-F · filed 2026-03-31 |
| 2025-06-30 | 31.06M EUR 6-K · filed 2025-09-30 |
| 2024-12-31 | 53.12M EUR 20-F · filed 2026-03-31 |
| 2024-06-30 | 69.76M EUR 6-K · filed 2024-09-18 |
| 2023-12-31 | 94.59M EUR 20-F · filed 2025-04-02 |
| 2023-06-30 | 23.01M EUR 6-K · filed 2023-09-26 |
| 2022-12-31 | 41.78M EUR 20-F · filed 2024-04-24 |
| 2022-06-30 | 63.61M EUR 6-K · filed 2022-09-28 |
| 2021-12-31 | 84.44M EUR 20-F · filed 2023-04-24 |
| 2021-06-30 | 102.83M EUR 6-K · filed 2021-09-08 |
| 2020-12-31 | 119.72M EUR 20-F · filed 2022-04-08 |
| 2019-12-31 | 35.63M EUR 20-F/A · filed 2021-04-08 |